Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sugar-free versus sugared CPC + benzocaine lozenge oral dissolution study
NL-OMON51112Active, not recruiting
- Sponsor
- Reckitt
- Start
- May 2021
- Modality
- Small Molecules, Conventional Liposomes → Liposomes → Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Randomised, open-label trial of cetylpyridinium chloride and benzocaine in pharyngitis and stomatitis (2 arms), sponsored by Reckitt. Primary endpoint: Comparability of dissolution profiles. Started May 2021; status: active, not recruiting.
02
Drugs
cetylpyridinium chloridebenzocaine
03
Conditions
pharyngitisstomatitis
Beyond the preview
Go deeper on NL-OMON51112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON51112.